This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The American Diabetes Association, publisher of Diabetes, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes in print and online a
This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The A...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
31-38Type 1 diabetes mellitus (T1DM) is characterized by lack of insulin production as a consequence...
OBJECTIVE—Non–Fc-binding anti-CD3–specific antibodies represent a promising therapy for preserving C...
<p>Diabetic NOD mice were treated with either a single injection of 50 µg anti-CD3 alone (•) or a si...
Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabet...
Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabet...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
This is an author-created, uncopyedited electronic version of an article accepted for publication in...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ t...
Studies in mice suggest that rapamycin has a negative impact on glucose homeostasis by inducing insu...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. ...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The A...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The A...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
31-38Type 1 diabetes mellitus (T1DM) is characterized by lack of insulin production as a consequence...
OBJECTIVE—Non–Fc-binding anti-CD3–specific antibodies represent a promising therapy for preserving C...
<p>Diabetic NOD mice were treated with either a single injection of 50 µg anti-CD3 alone (•) or a si...
Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabet...
Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabet...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
This is an author-created, uncopyedited electronic version of an article accepted for publication in...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
While rapamycin treatment has been reported to have a putatively negative effect on glucose homeosta...
Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ t...
Studies in mice suggest that rapamycin has a negative impact on glucose homeostasis by inducing insu...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. ...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The A...
This is an uncopyedited electronic version of an article accepted for publication in Diabetes. The A...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
31-38Type 1 diabetes mellitus (T1DM) is characterized by lack of insulin production as a consequence...
Add to ORKG